Which Tx Combo Is Best for HER2+ Breast Cancer?

The combination of trastuzumab deruxtecan (Enhertu) with pertuzumab (Perjeta) as a first-line treatment for HER2-positive advanced metastatic breast cancer has been shown to reduce the risk for disease progression or death by more than the current standard-of-care treatment. Sara Tolaney, MD, MPH Sara Tolaney, MD, MPH, of the Dana-Farber CancerContinue Reading

IL-23 Inhibitors Show Highest Drug Survival in Psoriasis

TOPLINE: Interleukin (IL)-23p19 inhibitors guselkumab and risankizumab demonstrated the highest drug survival for effectiveness and safety comparable with ustekinumab over 2 years, exceeding that of all other biologics. IL-17 receptor inhibitor brodalumab showed comparable effectiveness and safety with adalimumab and secukinumab. METHODOLOGY: Researchers conducted a cohort study using data fromContinue Reading

Tracking Triptan Safety During Pregnancy

TOPLINE: Prenatal exposure to triptans, alone or with other migraine medications, was not associated with a significantly increased risk for neurodevelopmental disorders (NDDs) in children born to mothers with a history of migraine in a new study. METHODOLOGY: Researchers conducted a registry-based cohort study in Norway, using data from multipleContinue Reading

Washington, D.C., May 30, 2025) – U.S. Secretary of Agriculture Brooke L. Rollins will visit Rome, Italy, on June 2-3. During her visit, Secretary Rollins will reinforce the Administration’s expectations for improved agricultural market access to Italy and the European Union and will encourage the United Nations organizations in RomeContinue Reading